title: Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?
authors.forename: Michael A
authors.initials: MA
authors.lastname: Nauck
authors.forename: Juris J
authors.initials: JJ
authors.lastname: Meier
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000819:agonists / Q000031:analogs & derivatives*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008687:Metformin / Q000627:therapeutic use; D010455:Peptides / Q000627:therapeutic use; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D045162:Thiazolidinediones / Q000627:therapeutic use; D014688:Venoms / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D010455:Peptides; D045162:Thiazolidinediones; D014688:Venoms; D000069036:Insulin Glargine; D052216:Glucagon-Like Peptide 1; D008687:Metformin; D000077270:Exenatide; D000077205:Pioglitazone